Subclinical hypothyroidism and subclinical hyperthyroidism

References

• Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr. Rev.29(1), 76–131 (2008).
   PubMed Web of Science ®Google Scholar
• Cooper DS. Approach to the patient with subclinical hyperthyroidism. J. Clin. Endocrinol. Metab.92(1), 3–9 (2007).
   PubMed Web of Science ®Google Scholar
• Andersen S, Pedersen KM, Bruun NH, Laurberg P. Narrow individual variations in serum T4 and T3 in normal subjects: a clue to the understanding of subclinical thyroid disease. J. Clin. Endocrinol. Metab.87(3), 1068–1072 (2002).
   PubMed Web of Science ®Google Scholar
• Ross DS. Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease. Endocrinol. Metab. Clin. North Am.30(2), 245–264, vii (2001).
   PubMed Web of Science ®Google Scholar
• McDermott MT, Ridgway EC. Subclinical hypothyroidism is mild thyroid failure and should be treated. J. Clin. Endocrinol. Metab.86(10), 4585–4590 (2001).
   PubMed Web of Science ®Google Scholar
• Spencer CA. Clinical utility and cost-effectiveness of sensitive thyrotropin assays in ambulatory and hospitalized patients. Mayo Clin. Proc.63(12), 1214–1222 (1988).
   PubMed Web of Science ®Google Scholar
• Hollowell JG, Staehling NW, Flanders WD et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab.87(2), 489–499 (2002).
   PubMed Web of Science ®Google Scholar
• Surks MI, Ortiz E, Daniels GH et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA291(2), 228–238 (2004).
   PubMed Web of Science ®Google Scholar
• Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J. Clin. Endocrinol. Metab.90(9), 5483–5488 (2005).
   PubMed Web of Science ®Google Scholar
• Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J. Clin. Endocrinol. Metab.92(12), 4575–4582 (2007).
   PubMed Web of Science ®Google Scholar
• Surks MI, Goswami G, Daniels GH. The thyrotropin reference range should remain unchanged. J. Clin. Endocrinol. Metab.90(9), 5489–5496 (2005).
   PubMed Web of Science ®Google Scholar
• Fatourechi V, Klee GG, Grebe SK et al. Effects of reducing the upper limit of normal TSH values. JAMA290(24), 3195–3196 (2003).
   PubMed Web of Science ®Google Scholar
• Spencer CA, Hollowell JG, Kazarosyan M, Braverman LE. National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. J. Clin. Endocrinol. Metab.92(11), 4236–4240 (2007).
   PubMed Web of Science ®Google Scholar
• Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J. Clin. Endocrinol. Metab.90(1), 581–585 (2005).
   PubMed Web of Science ®Google Scholar
• Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT; American Association of Clinical Endocrinologists; American Thyroid Association; Endocrine Society. Consensus Statement #1: subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. Thyroid15(1), 24–28 (2005).
   PubMed Web of Science ®Google Scholar
• Vanderpump MP, Tunbridge WM, French JM et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin. Endocrinol. (Oxf.)43(1), 55–68 (1995).
   PubMed Web of Science ®Google Scholar
• Brabant G, Prank K, Ranft U et al. Physiological regulation of circadian and pulsatile thyrotropin secretion in normal man and woman. J. Clin. Endocrinol. Metab.70(2), 403–409 (1990).
   PubMed Web of Science ®Google Scholar
• Park YJ, Lee EJ, Lee YJ et al. Subclinical hypothyroidism (SCH) is not associated with metabolic derangement, cognitive impairment, depression or poor quality of life (QoL) in elderly subjects. Arch. Gerontol. Geriatr.50(3), e68–e73 (2010).
   PubMed Web of Science ®Google Scholar
• Glinoer D. What happens to the normal thyroid during pregnancy? Thyroid9(7), 631–635 (1999).
   PubMed Web of Science ®Google Scholar
• Brabant G, Beck-Peccoz P, Jarzab B et al. Is there a need to redefine the upper normal limit of TSH? Eur. J. Endocrinol.154(5), 633–637 (2006).
   PubMed Web of Science ®Google Scholar
• Boucai L, Surks MI. Reference limits of serum TSH and free T4 are significantly influenced by race and age in an urban outpatient medical practice. Clin. Endocrinol. (Oxf.)70(5), 788–793 (2009).
   PubMed Web of Science ®Google Scholar
• Ladenson PW, Singer PA, Ain KB et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch. Intern. Med.60(11), 1573–1575 (2000); Erratum in Arch. Intern. Med.161(2), 284 (2001).
   Google Scholar
• Helfand M, Redfern CC; American College of Physicians. Clinical guideline, part 2: screening for thyroid disease: an update. Ann. Intern. Med.129(2), 144–158 (1998); Erratum in Ann. Intern. Med.130(3), 246 (1999).
   PubMed Web of Science ®Google Scholar
• Helfand M; U.S. Preventive Services Task Force. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann. Intern. Med.140(2), 128–141 (2004).
   PubMed Web of Science ®Google Scholar
• Hollowell JG, LaFranchi S, Smallridge RC, Spong CY, Haddow JE, Boyle CA. 2004 where do we go from here? Summary of working group discussions on thyroid function and gestational outcomes. Thyroid15(1), 72–76 (2005).
   PubMed Web of Science ®Google Scholar
• Haddow JE, Palomaki GE, Allan WC et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N. Engl. J. Med.341(8), 549–555 (1999).
   PubMed Web of Science ®Google Scholar
• Surks MI. Commentary: subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J. Clin. Endocrinol. Metab.90(1), 586–587 (2005).
   Web of Science ®Google Scholar
• Vaidya B, Anthony S, Bilous M et al. Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding? J. Clin. Endocrinol. Metab.92(1), 203–207 (2007).
   PubMed Web of Science ®Google Scholar
• Committee on Patient Safety and Quality Improvement; Committee on Professional Liability. ACOG Committee Opinion No. 381: subclinical hypothyroidism in pregnancy. Obstet. Gynecol.110(4), 959–960 (2007).
   PubMedGoogle Scholar
• Radacsi A, Bernard W, Feldkamp J, Horster FA, Szabolcs I. Follow up of thyroid hormone parameters in chronically ill geriatric patients: screening for thyroid disorders at hospital admission justified. Exp. Clin. Endocrinol. Diabetes108(4), 290–293 (2000).
   PubMed Web of Science ®Google Scholar
• Fatourechi V. Subclinical hypothyroidism: an update for primary care physicians. Mayo Clin. Proc.84(1), 65–71 (2009).
   PubMed Web of Science ®Google Scholar
• Cooper DS. Subclinical thyroid disease: a clinician’s perspective. Ann. Intern. Med.129(2), 135–138 (1998).
   PubMed Web of Science ®Google Scholar
• Cooper DS. Clinical practice: subclinical hypothyroidism. N. Engl. J. Med.345(4), 260–265 (2001).
   PubMed Web of Science ®Google Scholar
• Franklyn JA. Subclinical thyroid disorders: consequences and implications for treatment. Ann. Endocrinol. (Paris)68(4), 229–230 (2007).
   PubMed Web of Science ®Google Scholar
• Peeters RP, van der Deure WM, Visser TJ. Genetic variation in thyroid hormone pathway genes: polymorphisms in the TSH receptor and the iodothyronine deiodinases. Eur. J. Endocrinol.155(5), 655–662 (2006).
   PubMed Web of Science ®Google Scholar
• Diez JJ, Iglesias P. An analysis of the natural course of subclinical hyperthyroidism. Am. J. Med. Sci.337(4), 225–232 (2009).
   PubMed Web of Science ®Google Scholar
• Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch. Intern. Med.160(4), 526–534 (2000).
   PubMed Web of Science ®Google Scholar
• Choi AR, Manning P. Overshooting the mark: subclinical hyperthyroidism secondary to excess thyroid hormone treatment may be more prevalent than we realise. NZ Med. J.122(1289), 93–94 (2009).
   PubMedGoogle Scholar
• Charkes ND. The many causes of subclinical hyperthyroidism. Thyroid6(5), 391–396 (1996).
   PubMed Web of Science ®Google Scholar
• Hovens GC, Stokkel MP, Kievit J et al. Associations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer. J. Clin. Endocrinol. Metab.92(7), 2610–2615 (2007).
   PubMed Web of Science ®Google Scholar
• Bjorndal MM, Sandmo Wilhelmsen K, Lu T, Jorde R. Prevalence and causes of undiagnosed hyperthyroidism in an adult healthy population: the Tromso study. J. Endocrinol. Invest.31(10), 856–860 (2008).
   PubMed Web of Science ®Google Scholar
• Diez JJ. Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management. Gerontology49(5), 316–323 (2003).
   PubMed Web of Science ®Google Scholar
• Toft AD. Clinical practice: subclinical hyperthyroidism. N. Engl. J. Med.345(7), 512–516 (2001).
   PubMed Web of Science ®Google Scholar
• Casey BM, Dashe JS, Wells CE, McIntire DD, Leveno KJ, Cunningham FG. Subclinical hyperthyroidism and pregnancy outcomes. Obstet. Gynecol.107(2 Pt 1), 337–341 (2006).
   PubMed Web of Science ®Google Scholar
• Marx H, Amin P, Lazarus JH. Hyperthyroidism and pregnancy. BMJ336(7645), 663–667 (2008); Erratum in BMJ DOI: 10.1136/bmj.39545.531771.AD (2010).
   PubMed Web of Science ®Google Scholar
• Lazarus JH. Thyroid disorders associated with pregnancy: etiology, diagnosis, and management. Treat. Endocrinol.4(1), 31–41 (2005).
   PubMedGoogle Scholar
• Woeber KA. Observations concerning the natural history of subclinical hyperthyroidism. Thyroid15(7), 687–691 (2005).
   PubMed Web of Science ®Google Scholar
• Biondi B, Palmieri EA, Klain M, Schlumberger M, Filetti S, Lombardi G. Subclinical hyperthyroidism: clinical features and treatment options. Eur. J. Endocrinol.152(1), 1–9 (2005).
   PubMed Web of Science ®Google Scholar
• Eustatia-Rutten CF, Corssmit EP, Pereira AM et al. Quality of life in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomized controlled trial. Clin. Endocrinol. (Oxf.)64(3), 284–291 (2006).
   PubMed Web of Science ®Google Scholar
• Samuels MH. Cognitive function in untreated hypothyroidism and hyperthyroidism. Curr. Opin. Endocrinol. Diabetes Obes.15(5), 429–433 (2008).
   PubMedGoogle Scholar
• Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet358(9285), 861–865 (2001).
   PubMed Web of Science ®Google Scholar
• Ochs N, Auer R, Bauer DC et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann. Intern. Med.148(11), 832–845 (2008).
   PubMed Web of Science ®Google Scholar
• Biondi B, Palmieri EA, Fazio S et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J. Clin. Endocrinol. Metab.85(12), 4701–4705 (2000).
   PubMed Web of Science ®Google Scholar
• Biondi B, Fazio S, Cuocolo A et al. Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine. J. Clin. Endocrinol. Metab.81(12), 4224–4228 (1996).
   PubMed Web of Science ®Google Scholar
• Owecki M, Michalak A, Nikisch E, Sowinski J. Prolonged ventricular repolarization measured by corrected QT interval (QTc) in subclinical hyperthyroidism. Horm. Metab. Res.38(1), 44–47 (2006).
   PubMed Web of Science ®Google Scholar
• Rodondi N, Bauer DC, Cappola AR et al. Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure: the Cardiovascular Health Study. J. Am. Coll. Cardiol.52(14), 1152–1159 (2008).
   PubMed Web of Science ®Google Scholar
• Rosario PW, Borges MA, Purisch S. Effects of the restoration of euthyroidism after chronic suppressive therapy with levothyroxine in patients with thyroid cancer. Endocrinologist19(2), 58–59 (2009).
   Google Scholar
• Iqbal A, Schirmer H, Lunde P, Figenschau Y, Rasmussen K, Jorde R. Thyroid stimulating hormone and left ventricular function. J. Clin. Endocrinol. Metab.92(9), 3504–3510 (2007).
   PubMed Web of Science ®Google Scholar
• Sawin CT. Subclinical hyperthyroidism and atrial fibrillation. Thyroid12(6), 501–503 (2002).
   PubMed Web of Science ®Google Scholar
• Gammage MD, Parle JV, Holder RL et al. Association between serum free thyroxine concentration and atrial fibrillation. Arch. Intern. Med.167(9), 928–934 (2007).
   PubMedGoogle Scholar
• Ross DS. Hyperthyroidism, thyroid hormone therapy, and bone. Thyroid4(3), 319–326 (1994).
   PubMed Web of Science ®Google Scholar
• Kim DJ, Khang YH, Koh JM, Shong YK, Kim GS. Low normal TSH levels are associated with low bone mineral density in healthy postmenopausal women. Clin. Endocrinol. (Oxf.)64(1), 86–90 (2006).
   PubMed Web of Science ®Google Scholar
• Bauer DC, Ettinger B, Nevitt MC, Stone KL; Study of Osteoporotic Fractures Research Group. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann. Intern. Med.134(7), 561–568 (2001).
   PubMed Web of Science ®Google Scholar
• Morris MS. The association between serum thyroid-stimulating hormone in its reference range and bone status in postmenopausal American women. Bone40(4), 1128–1134 (2007).
   PubMed Web of Science ®Google Scholar
• Reverter JL, Holgado S, Alonso N, Salinas I, Granada ML, Sanmarti A. Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma. Endocr. Relat. Cancer12(4), 973–981 (2005).
   PubMed Web of Science ®Google Scholar
• Kalmijn S, Mehta KM, Pols HA, Hofman A, Drexhage HA, Breteler MM. Subclinical hyperthyroidism and the risk of dementia: the Rotterdam study. Clin. Endocrinol. (Oxf.)53(6), 733–737 (2000).
   PubMed Web of Science ®Google Scholar
• Dobert N, Hamscho N, Menzel C et al. Subclinical hyperthyroidism in dementia and correlation of the metabolic index in FDG-PET. Acta Med. Austriaca30(5), 130–133 (2003).
   PubMedGoogle Scholar
• van Osch LA, Hogervorst E, Combrinck M, Smith AD. Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease. Neurology62(11), 1967–1971 (2004).
   PubMed Web of Science ®Google Scholar
• Roberts LM, Pattison H, Roalfe A et al. Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction? Ann. Intern. Med.145(8), 573–581 (2006).
   PubMed Web of Science ®Google Scholar
• Brennan MD, Powell C, Kaufman KR, Sun PC, Bahn RS, Nair KS. The impact of overt and subclinical hyperthyroidism on skeletal muscle. Thyroid16(4), 375–380 (2006).
   PubMed Web of Science ®Google Scholar
• Greenlund LJ, Nair KS, Brennan MD. Changes in body composition in women following treatment of overt and subclinical hyperthyroidism. Endocr. Pract.14(8), 973–978 (2008).
   PubMedGoogle Scholar
• Bober SA, McGill AC, Tunbridge WM. Thyroid function in hyperemesis gravidarum. Acta Endocrinol. (Copenh.)111(3), 404–410 (1986).
   PubMedGoogle Scholar
• Dorr M, Ruppert J, Robinson DM, Kors JA, Felix SB, Volzke H. The relation of thyroid function and ventricular repolarization: decreased serum thyrotropin levels are associated with short rate-adjusted QT intervals. J. Clin. Endocrinol. Metab.91(12), 4938–4942 (2006).
   PubMed Web of Science ®Google Scholar
• Gow SM, Nicol K, Seth J, Caldwell G, Toft AD, Beckett GJ. Laboratory and diagnostic performance of a coated well immunoradiometric assay for serum thyrotrophin. Ann. Clin. Biochem.24(Pt 3), 273–278 (1987).
   PubMed Web of Science ®Google Scholar
• Eustatia-Rutten CF, Corssmit EP, Heemstra KA et al. Autonomic nervous system function in chronic exogenous subclinical thyrotoxicosis and the effect of restoring euthyroidism. J. Clin. Endocrinol. Metab.93(7), 2835–2841 (2008).
   PubMed Web of Science ®Google Scholar
• Goichot B, Sapin R, Schlienger JL. Subclinical hyperthyroidism: considerations in defining the lower limit of the thyrotropin reference interval. Clin. Chem.55(3), 420–424 (2009).
   PubMed Web of Science ®Google Scholar
• Haden ST, Marqusee E, Utiger RD. Subclinical hyperthyroidism. Endocrinologist6(4), 322–327 (1996).
   Google Scholar
• Burch HB, Shakir F, Fitzsimmons TR, Jaques DP, Shriver CD. Diagnosis and management of the autonomously functioning thyroid nodule: the Walter Reed Army Medical Center experience, 1975–1996. Thyroid8(10), 871–880 (1998).
   PubMed Web of Science ®Google Scholar
• Col NF, Surks MI, Daniels GH. Subclinical thyroid disease: clinical applications. JAMA291(2), 239–243 (2004).
   PubMed Web of Science ®Google Scholar
• Laurberg P, Andersen S, Bulow Pedersen I, Carle A. Hypothyroidism in the elderly: pathophysiology, diagnosis and treatment. Drugs Aging22(1), 23–38 (2005).
   PubMed Web of Science ®Google Scholar
• Tunbridge WM, Vanderpump MP. Population screening for autoimmune thyroid disease. Endocrinol. Metab. Clin. North Am.29(2), 239–253, v (2000).
   PubMed Web of Science ®Google Scholar
• Fatourechi V, Lankarani M, Schryver PG, Vanness DJ, Long KH, Klee GG. Factors influencing clinical decisions to initiate thyroxine therapy for patients with mildly increased serum thyrotropin (5.1–10.0 mIU/L). Mayo Clin. Proc.78(5), 554–560 (2003).
   PubMed Web of Science ®Google Scholar
• Chu JW, Crapo LM. The treatment of subclinical hypothyroidism is seldom necessary. J. Clin. Endocrinol. Metab.86(10), 4591–4599 (2001).
   PubMed Web of Science ®Google Scholar
• Rosario PW, Bessa B, Valadao MM, Purisch S. Natural history of mild subclinical hypothyroidism: prognostic value of ultrasound. Thyroid19(1), 9–12 (2009).
   PubMed Web of Science ®Google Scholar
• Diez JJ, Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J. Clin. Endocrinol. Metab.89(10), 4890–4897 (2004).
   PubMed Web of Science ®Google Scholar
• Kong WM, Sheikh MH, Lumb PJ et al. A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. Am. J. Med.112(5), 348–354 (2002); Erratum in Am. J. Med.113(3), 264 (2002).
   PubMed Web of Science ®Google Scholar
• Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC. l-thyroxine therapy in subclinical hypothyroidism: a double-blind, placebo-controlled trial. Ann. Intern. Med.101(1), 18–24 (1984).
   PubMed Web of Science ®Google Scholar
• Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frolich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA292(21), 2591–2599 (2004).
   PubMed Web of Science ®Google Scholar
• Jorde R, Waterloo K, Storhaug H, Nyrnes A, Sundsfjord J, Jenssen TG. Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment. J. Clin. Endocrinol. Metab.91(1), 145–153 (2006).
   PubMed Web of Science ®Google Scholar
• Zhu DF, Wang ZX, Zhang DR et al. fMRI revealed neural substrate for reversible working memory dysfunction in subclinical hypothyroidism. Brain129(Pt 11), 2923–2930 (2006).
   PubMed Web of Science ®Google Scholar
• Wu T, Flowers JW, Tudiver F, Wilson JL, Punyasavatsut N. Subclinical thyroid disorders and cognitive performance among adolescents in the United States. BMC Pediatr.6, 12 (2006).
   PubMedGoogle Scholar
• Villar HC, Saconato H, Valente O, Atallah AN. Thyroid hormone replacement for subclinical hypothyroidism. Cochrane Database Syst. Rev. (3), CD003419 (2007).
   Google Scholar
• Danese MD, Ladenson PW, Meinert CL, Powe NR. Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J. Clin. Endocrinol. Metab.85(9), 2993–3001 (2000).
   Google Scholar
• Erem C. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Clin. Endocrinol. (Oxf.)64(3), 323–329 (2006).
   PubMed Web of Science ®Google Scholar
• Al Sayed A, Al Ali N, Bo Abbas Y, Alfadhli E. Subclinical hypothyroidism is associated with early insulin resistance in Kuwaiti women. Endocr. J.53(5), 653–657 (2006).
   PubMed Web of Science ®Google Scholar
• Takashima N, Niwa Y, Mannami T, Tomoike H, Iwai N. Characterization of subclinical thyroid dysfunction from cardiovascular and metabolic viewpoints: the Suita study. Circ. J.71(2), 191–195 (2007).
   PubMed Web of Science ®Google Scholar
• Hueston WJ, King DE, Geesey ME. Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism. Clin. Endocrinol. (Oxf.)63(5), 582–587 (2005).
   PubMed Web of Science ®Google Scholar
• Meek S, Smallridge RC. Effect of thyroid hormone replacement on methionine-stimulated homocysteine levels in patients with subclinical hypothyroidism: a randomized, double-blind, placebo-controlled study. Endocr. Pract.12(5), 529–534 (2006).
   PubMedGoogle Scholar
• Duntas LH, Wartofsky L. Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors: what is the evidence? Thyroid17(11), 1075–1084 (2007).
   PubMed Web of Science ®Google Scholar
• Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver JU. The beneficial effect of l-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J. Clin. Endocrinol. Metab.92(5), 1715–1723 (2007).
   PubMed Web of Science ®Google Scholar
• Perez A, Cubero JM, Sucunza N et al. Emerging cardiovascular risk factors in subclinical hypothyroidism: lack of change after restoration of euthyroidism. Metabolism53(11), 1512–1515 (2004).
   PubMed Web of Science ®Google Scholar
• Erdal M, Sahin M, Saglam K et al. Increased serum chitotriosidase activity following restoration of euthyroidism in patients with subclinical hypothyroidism. Intern. Med.47(14), 1309–1314 (2008).
   PubMed Web of Science ®Google Scholar
• Bell RJ, Rivera-Woll L, Davison SL, Topliss DJ, Donath S, Davis SR. Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease: a community-based study. Clin. Endocrinol. (Oxf.)66(4), 548–556 (2007).
   PubMed Web of Science ®Google Scholar
• Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann. Intern. Med.132(4), 270–278 (2000).
   PubMed Web of Science ®Google Scholar
• Vanderpump MP, Tunbridge WM, French JM et al. The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid6(3), 155–160 (1996).
   PubMed Web of Science ®Google Scholar
• Cappola AR, Fried LP, Arnold AM et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA295(9), 1033–1041 (2006).
   PubMed Web of Science ®Google Scholar
• Rodondi N, Aujesky D, Vittinghoff E, Cornuz J, Bauer DC. Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. Am. J. Med.119(7), 541–551 (2006).
   PubMed Web of Science ®Google Scholar
• Singh S, Duggal J, Molnar J, Maldonado F, Barsano CP, Arora R. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. Int. J. Cardiol.125(1), 41–48 (2008).
   PubMed Web of Science ®Google Scholar
• Haentjens P, Van Meerhaeghe A, Poppe K, Velkeniers B. Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. Eur. J. Endocrinol.159(3), 329–341 (2008).
   PubMed Web of Science ®Google Scholar
• Razvi S, Shakoor A, Vanderpump M, Weaver JU, Pearce SH. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J. Clin. Endocrinol. Metab.93(8), 2998–3007 (2008).
   PubMed Web of Science ®Google Scholar
• Atzmon G, Barzilai N, Hollowell JG, Surks MI, Gabriely I. Extreme longevity is associated with increased serum thyrotropin. J. Clin. Endocrinol. Metab.94(4), 1251–1254 (2009).
   PubMed Web of Science ®Google Scholar
• Biondi B. Cardiovascular effects of mild hypothyroidism. Thyroid17(7), 625–630 (2007).
   PubMed Web of Science ®Google Scholar
• Baycan S, Erdogan D, Caliskan M et al. Coronary flow reserve is impaired in subclinical hypothyroidism. Clin. Cardiol.30(11), 562–566 (2007).
   PubMed Web of Science ®Google Scholar
• Owen PJ, Rajiv C, Vinereanu D, Mathew T, Fraser AG, Lazarus JH. Subclinical hypothyroidism, arterial stiffness, and myocardial reserve. J. Clin. Endocrinol. Metab.91(6), 2126–2132 (2006).
   PubMed Web of Science ®Google Scholar
• Franzoni F, Galetta F, Fallahi P et al. Effect of l-thyroxine treatment on left ventricular function in subclinical hypothyroidism. Biomed. Pharmacother.60(8), 431–436 (2006).
   PubMed Web of Science ®Google Scholar
• Glinoer D. Potential repercussions for the progeny of maternal hypothyroxinemia during pregnancy. Thyroid10(1), 59–62 (2000).
   PubMed Web of Science ®Google Scholar
• LaFranchi SH, Haddow JE, Hollowell JG. Is thyroid inadequacy during gestation a risk factor for adverse pregnancy and developmental outcomes? Thyroid15(1), 60–71 (2005).
   PubMed Web of Science ®Google Scholar
• Haddow JE; Thyroid Study Group. Subclinical hypothyroidism and pregnancy outcomes. Obstet. Gynecol.106(1), 198; author reply 198–199 (2005).
   PubMedGoogle Scholar
• Casey BM, Dashe JS, Wells CE et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet. Gynecol.105(2), 239–245 (2005).
   PubMed Web of Science ®Google Scholar
• Benhadi N, Wiersinga WM, Reitsma JB, Vrijkotte TG, Bonsel GJ. Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur. J. Endocrinol.160(6), 985–991 (2009).
   PubMed Web of Science ®Google Scholar
• Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J. Clin. Endocrinol. Metab.91(7), 2587–2591 (2006).
   PubMed Web of Science ®Google Scholar
• Christ-Crain M, Meier C, Huber PR, Staub JJ, Muller B. Effect of l-thyroxine replacement therapy on surrogate markers of skeletal and cardiac function in subclinical hypothyroidism. Endocrinologist14(3), 161–166 (2004).
   Google Scholar
• Monzani F, Caraccio N, Del Guerra P, Casolaro A, Ferrannini E. Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of l-T4 replacement therapy. Clin. Endocrinol. (Oxf.)51(2), 237–242 (1999).
   PubMed Web of Science ®Google Scholar
• Caraccio N, Natali A, Sironi A, Baldi S, Frascerra S, Dardano A et al. Muscle metabolism and exercise tolerance in subclinical hypothyroidism: a controlled trial of levothyroxine. J. Clin. Endocrinol. Metab.90(7), 4057–4062 (2005).
   PubMed Web of Science ®Google Scholar
• Misiunas A, Niepomniszcze H, Ravera B, Faraj G, Faure E. Peripheral neuropathy in subclinical hypothyroidism. Thyroid5(4), 283–286 (1995).
   PubMed Web of Science ®Google Scholar
• Arikan E, Pekindil G, Guldiken S, Pekindil Y. The evaluation of the median nerve in subclinical hypothyroidism by high-resolution sonography. Endocrinologist15(4), 209–212 (2005).
   Google Scholar
• Haggerty JJ Jr, Garbutt JC, Evans DL et al. Subclinical hypothyroidism: a review of neuropsychiatric aspects. Int. J. Psychiatry Med.20(2), 193–208 (1990).
   PubMed Web of Science ®Google Scholar
• Holtmann M, Duketis E, Goth K, Poustka L, Boelte S. Severe affective and behavioral dysregulation in youth is associated with increased serum TSH. J. Affect. Disord.121(1–2), 184–188 (2009).
   PubMed Web of Science ®Google Scholar
• Post RM, Kramlinger KG, Joffe RT et al. Rapid cycling bipolar affective disorder: lack of relation to hypothyroidism. Psychiatry Res.72(1), 1–7 (1997).
   PubMed Web of Science ®Google Scholar
• Williams MD, Harris R, Dayan CM, Evans J, Gallacher J, Ben-Shlomo Y. Thyroid function and the natural history of depression: findings from the Caerphilly Prospective Study (CaPS) and a meta-analysis. Clin. Endocrinol. (Oxf.)70(3), 484–492 (2009).
   PubMed Web of Science ®Google Scholar
• Pollock MA, Sturrock A, Marshall K et al. Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: randomised double blind placebo controlled crossover trial. BMJ323(7318), 891–895 (2001).
   PubMedGoogle Scholar
• Santini F, Pinchera A, Marsili A et al. Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases. J. Clin. Endocrinol. Metab.90(1), 124–127 (2005).
   PubMed Web of Science ®Google Scholar
• Meier C, Staub JJ, Roth CB et al. TSH-controlled l-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J. Clin. Endocrinol. Metab.86(10), 4860–4866 (2001).
   PubMed Web of Science ®Google Scholar
• Haggerty JJ Jr, Prange AJ Jr. Borderline hypothyroidism and depression. Annu. Rev. Med.46, 37–46 (1995).
   PubMed Web of Science ®Google Scholar
• Jaeschke R, Guyatt G, Gerstein H et al. Does treatment with l-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? J. Gen. Intern. Med.11(12), 744–749 (1996).
   PubMed Web of Science ®Google Scholar
• Nystrom E, Caidahl K, Fager G, Wikkelso C, Lundberg PA, Lindstedt G. A double-blind cross-over 12-month study of l-thyroxine treatment of women with ‘subclinical’ hypothyroidism. Clin. Endocrinol. (Oxf.)29(1), 63–75 (1988).
   PubMed Web of Science ®Google Scholar
• Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of subclinical thyroid dysfunction on the heart. Ann. Intern. Med.137(11), 904–914 (2002).
   PubMed Web of Science ®Google Scholar